SCHEMBL20129626

SCHEMBL20129626

O=C1CN(c2ccccc2)CCN1Cc1ccc(CO)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 3/20 0.54
WDR77 Q9BQA1 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.47
ENPP2 Q13822 2/20 0.45
DRD4 P21917 1/20 0.44
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
TRPC5 Q9UL62 1/20 0.41
GFER P55789 1/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
ADRA1D P25100 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20133744 0.82 SIGMAR1 (0.51) KMT2AALDH1A1MEN1MAPTADRA1D
SCHEMBL28710495 0.78 PTGS2 (0.46) PRMT5L3MBTL1DRD4KMT2APOLB
SCHEMBL28296992 0.77 MEN1 (0.57) L3MBTL1KMT2AALDH1A1MEN1MAPT
SCHEMBL22623625 0.75 CHRNA7 (0.53) PRMT5WDR77POLBALDH1A1ADRA1A
SCHEMBL3242189 0.75 DRD4 (0.77) DRD4ALDH1A1KDM4EHTT
SCHEMBL11126838 0.75 PRMT5 (0.41) PRMT5WDR77DRD4ALDH1A1KDM4E
SCHEMBL20129639 0.74 MAPK1 (0.40) L3MBTL1ENPP2KMT2APOLBCYP2D6
SCHEMBL12451876 0.72 HDAC1 (0.66) KMT2APOLBCYP2D6CYP2C9CYP2C19
SCHEMBL24154458 0.72 LMNA (0.56) L3MBTL1KMT2AGFERALDH1A1MEN1
SCHEMBL28497387 0.72 MCHR1 (0.57) PRMT5WDR77L3MBTL1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR PRMT5 81/4885WDR77 537/4885L3MBTL1 3865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.